Preliminary safety and clinical activity of atezolizumab combined with cobimetinib and vemurafenib in BRAF V600-mutant metastatic melanoma von Hwu, P., Hamid, O., Gonzalez, R., Infante, J.R., Patel, M.R., Hodi, F.S., Lewis, K.D., Wallin, J., Mwawasi, G., Cha, E., Richie, N., Ballinger, M., Sullivan, R.

Volltext

LBA-01Safety and efficacy of cobimetinib (cobi) and atezolizumab (atezo) in a Phase 1b study of metastatic colorectal cancer (mCRC) von Bendell, J, Tae Won, K, Cheng Ean, C, Yung-Jue, B, Lee, C, Desai, J, Lewin, J, Wallin, J, Das Thakur, M, Mwawasi, G, Cha, E, Infante, J

Volltext

LBA-01 Safety and efficacy of cobimetinib (cobi) and atezolizumab (atezo) in a Phase 1b study of metastatic colorectal cancer (mCRC) von Bendell, J., Tae Won, K., Cheng Ean, C., Yung-Jue, B., Lee, C., Desai, J., Lewin, J., Wallin, J., Das Thakur, M., Mwawasi, G., Cha, E., Infante, J.

Volltext

Efficacy and safety of cobimetinib (cobi) and atezolizumab (atezo) in an expanded phase 1b study of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) von Desai, J., Hong, Y.S., Kim, J.E., Kim, T.W., Han, S.W., Bang, Y.-J., Chee, C.E., Heong, V.Y.M., McRee, A., Chow, L.Q., Kwak, E.L., Infante, J.R., Wallin, J., Thakur, M. Das, Mwawasi, G., Foster, P., Cha, E., Bendell, J.C.

Volltext

Dalteparin in combination with abciximab during percutaneous coronary intervention von Kereiakes, Dean J., Kleiman, Neal S., Fry, Edward, Mwawasi, Grace, Lengerich, Rose, Maresh, Kelly, Burkert, Mary Lynn, Aquilina, Joseph W., DeLoof, Michael, Broderick, Thomas M., Shimshak, Thomas M.

Volltext

475-PA11 Risk factors for asthma in Kenya school children von Odhiambo, J., Ng'ang'a, L., Mungai, M., Gicheha, C., Nyamwaya, J., Mwawasi, G., Becklake, M.R., Menzies, R., Macklem, P.T.

Volltext

T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity von Helsen, C.W, Hammill, J, Mwawasi, K, Lau, V, Hayes, D, Afsahi, A, Bezverbnaya, K, Newhook, L, Aarts, C, Denisova, G, Bramson, J

Volltext

4 - T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity von Helsen, C.W., Hammill, J., Mwawasi, K., Lau, V., Hayes, D., Afsahi, A., Bezverbnaya, K., Newhook, L., Aarts, C., Denisova, G., Bramson, J.

Volltext